HealthFDA Under Fire for Greenlighting Controversial Opioid Addiction Genetic Test 'AvertD' Amid Opioid Crisis FDA faces backlash over approval of AvertD genetic test for opioid addiction risk. Concerns arise about efficacy and the potential impact on prescribing practices.by John Lopez
HealthCellphone Compass Enables Precision Measurements, Revolutionizing Glucose Monitoringby Inno Flores